SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biomatrix (BXM) Looking Great
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
569 7 0 BXM
Emcee:  Andy Wall Type:  Unmoderated
Introduction Market Data Compact
Biomatrix recently reported great earnings of $.50/share
last quarter as opposed to a loss in previous quarters. I heard
great things about this company from a friend. Biomatrix makes
many drugs including their biggest prospect called Synvisc. Synvisc
is a drug that is used to treat arthritis. FDA approval is supposed
to be coming real, real soon. The product I guess has done extremely
well in Europe and Canada causing the great increase in income last
quarter. I really feel the company has great potential. I have also
heard from my friend that insiders own a great portion of the stock.

Looking at the chart it looks like the time to get in is now.
If anyone has been following this stock I would greatly
appreciate your comments and feedback about the company. I would also
appreciate it if anyone could confirm, or at least tell me how to find
out about the insider holdings.

Thanks in advance, Andy
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
569 Skeeter, Loooks like the deal is still on but everybody's question is at wBill Hyres-4/13/2000
568 is bxm going to be bought by genz or is it off?Skeeter Bug-4/12/2000
567 Wednesday March 29, 8:41 am Eastern Time Company Press Release SOURCE: Biomatscaram(o)uche-3/29/2000
566 Here's my read: They have offered enough cash to convert 28+% bxm shares atGreg Jung-3/23/2000
565 SEC filing, 28.38% cash? 71.62% stock? can some more knowledgeable explain thiMichael D. Christian-3/23/2000
564biz.yahoo.com Wednesday March 22, 9:13 am Eastern Time Company Press Release scaram(o)uche-3/22/2000
563 more regarding HIF-1 alpha competitors...... Tuesday March 21, 12:31 pm Easterscaram(o)uche-3/21/2000
562 Rick, the news from CLTX is all the more impressive because just last week CHIRJMarcus-3/20/2000
561cbs.marketwatch.com Screamers Collateral Therapeutics rises oscaram(o)uche-3/20/2000
560 If the cash is oversubscribed, cash+stock will be alloted. As price drops, chaGreg Jung-3/10/2000
559 why it droppedtony-3/10/2000
558 Maybe they've got enough insiders and other holders on board. All they neeGreg Jung-3/8/2000
557 "BXM gets a cash guarantee" if so why is there only 250m cash or 1/3dalroi-3/7/2000
556 Its not a buyout but a spinoff+combo with GZTR, GZSP. BXM gets a cash guaranteeGreg Jung-3/6/2000
555 Genzyme to buy BXM for about $800 Million Enjoy, AnthonyAnthony Tsai-3/6/2000
554 BXM beats earnings estimates. Reported $.18/share. Mean was $.17/share EnjoyAnthony Tsai-2/22/2000
553 16% owned by Inst. 16.5% owned by insiders. Zacks has this info as do many oRMA-2/14/2000
552 Nice cup-and-handle formation. The earnings will determine whether the uptrend Ted The Technician-2/11/2000
551 Warburg Dillon Read initiating coverage on BXM with a BUY RATING and 12-month pAnthony Tsai-1/13/2000
550 BXM gets CE Mark Approval For Ophtalmic Product BXM, Medical Device LaboratoriAnthony Tsai-12/1/1999
549 I think BXM doing their own marketing in Canada and keeping more of the revenueJames Baker-11/19/1999
548 Biomatrix To Market Synvisc In CanadaAnthony Tsai-11/19/1999
547 BXM had positive comments in this article: cbs.marketwatch.comAnthony Tsai-10/26/1999
546 10/25 8:15A (DJ) =DJ HEARD ON THE NET: Harsh Rumors Dog Biomatrix Anthony Tsai-10/25/1999
545 BXM has stated that in preparation for the direct marketing push during the 3rdJames Baker-10/24/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News